Clayton brings substantial cross-border M&A, equity and debt advisory experience to the firm. He was previously a senior vice president with Jefferies’ Hong Kong investment banking team, and prior to that, served as an investment banking director in UBS’ Hong Kong office. Clayton holds a bachelor’s degree from Williams College and a Master of Business Administration degree from the University of Chicago Booth School of Business.
'Piper Jaffray identified Andy as a proven leader to help strengthen our Asia investment banking efforts. His track record, global perspective and longstanding relationships will contribute meaningfully to our global healthcare franchise', commented Scott LaRue, global co-head of investment banking and capital markets.
'We are excited to have someone of Andy’s caliber join our Asia team', said JP Peltier, head of Piper Jaffray healthcare investment banking. 'His healthcare experience, fluency in Mandarin Chinese and regional knowledge will greatly complement our strengths in Asia'.
Piper Jaffray has a global healthcare investment banking and capital markets team of more than 50 professionals. Since 2007, the team has represented clients in 325 transactions with an aggregate value of $55bn. Year-to-date, the Piper Jaffray healthcare investment banking group has advised on 17 M&A transactions and 32 financings for an aggregate value of $9.95bn.
In addition, the firm’s 10 healthcare senior research analysts cover a broad spectrum of sectors, including biotechnology, medical technology, specialty pharmaceuticals, drug discovery, medical diagnostics, life science tools and healthcare services, including information technology and alternate site providers.